GLP1 receptors are present in many tissues, but with regards to the therapeutic effects on diabetes, their activation is thought to increase insulin secretion, and reduce beta cell apoptosis and glucagon release in a glucose-dependent way [71]. This evidence concerns the gene GLP1R and diabetes mellitus.